Results 91 to 100 of about 3,444 (186)

Dynamics of myocardial necrosis biomarkers and acid-base balance parameters after coronary artery bypass grafting on beating-heart depending on the perioperative glucose-lowering treatment regimen in patients with type II diabetes

Acta Biomedica Scientifica, 2015
The study included 71 patient with ischemic coronary disease (ICD) with type II diabetes mellitus (DM) treated by oral hypoglycemic agents undergoing off-pump coronary artery bypass grafting (CABG). The mean age was 59 (56-64) years.
S. Y. Borodashkina, K. V. Protasov, V. A. Podkamennyi   +2 more
doaj  

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development

Биопрепараты: Профилактика, диагностика, лечение, 2018
Development and improvement of biotechnological drugs currently more relevant than ever. Drugs obtained by means of biotechnology, have a number of positive qualities.
A. A. Lidzhieva, E. A. Smolyarchuk, A. E. Kokorina, V. V. Smirnov, E. A. Egorenkov   +4 more
doaj  

[Dysglycemia in COVID-19 and Type 2 Diabetes Mellitus: Peculiarities of the Glycemic Profile in Hospitalized Patients and the Role of Steroid-Induced Disorders]. [PDF]

Probl Endokrinol (Mosk), 2022
Strongin LG, Nekrasova TA, Belikina DV, Korneva KG, Petrov AV.   +4 more
europepmc   +1 more source

Более «пожилые» клетки островков Лангерганса лучше вырабатывают инсулин

Медицинский совет, 2016
Ученые из медицинской школы Адасса при Еврейском университете при участии американских и канадских исследователей сделали неожиданное открытие: процессы клеточного старения в тканях поджелудочной железы не только не ухудшают, но и, наоборот, улучшают ...
Editorial Article
doaj  

[Donohue syndrome and use of continuous subcutaneous IGF1 pump therapy]. [PDF]

Probl Endokrinol (Mosk), 2022
Melikyan MA, Ivannikova TE, Milovanova NV, Kolodkina AA, Bezlepkina OB, Mokryshevа NG.   +5 more
europepmc   +1 more source

Фармакоэкономическое сравнение базальных аналогов инсулина при сахарном диабете 2 типа

Качественная клиническая практика, 2018
Актуальность. Стоимостные аспекты применения инсулина гларгин и инсулина детемир являются предметом дискуссий. Прямое сравнение утилитарных стоимостей препаратов не даёт ответа на вопрос об экономичности той или иной программы лечения в отрыве от его ...

doaj  

[Imeglimin: features of the mechanism of action and potential benefits]. [PDF]

Probl Endokrinol (Mosk), 2022
Kuznetsov KO, Saetova AA, Mahmutova EI, Bobrik AG, Bobrik DV, Nagaev IR, Khamitova AD, Arapieva AM.   +7 more
europepmc   +1 more source

[Characteristics of purchases of hypoglycemic agents in pharmacy retail sector in 2016-2020 years dynamics]. [PDF]

Probl Endokrinol (Mosk), 2023
Kurkin DV, Makarova EV, Krysanov IS, Bakulin DA, Robertus AI, Ivanova OV, Kolosov YA, Kudrin RA.   +7 more
europepmc   +1 more source

[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]. [PDF]

Probl Endokrinol (Mosk), 2022
Berkovskaya MA, Gurova OY, Khaykina IA, Fadeev VV.   +3 more
europepmc   +1 more source

[Electroencephalogram features in children with congenital hyperinsulinism treated according to the international protocol in Russian Federation]. [PDF]

Probl Endokrinol (Mosk), 2023
Sarakaeva LR, Ryzhkova DV, Mitrofanova LB, Bairov VG, Sukhotskaya AA, Smorodin AP, Eftich EA, Kelmanson IA, Nikitina IL.   +8 more
europepmc   +1 more source